Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.5 (EPT/RI) Pfizer Inc

8th May 2014 10:06

RNS Number : 5829G
Morgan Stanley Capital Services LLC
08 May 2014
 



 

 FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley Capital Services LLC

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

PFIZER INC

(c) Name of the party to the offer with which exempt principal trader is connected:

 

ASTRAZENECA PLC

(d) Date dealing undertaken:

07 MAY 2014

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

YES

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

 Class of relevant security

 Purchases/sales

 Total number of securities

 Highest price per unit paid/received

 Lowest price per unit paid/received

 COMMON STOCK

 PURCHASES

 297,531

 29.3500 USD

 28.8550 USD

 COMMON STOCK

 SALES

 415,462

 29.3800 USD

 28.8500 USD

 

 

(b) Derivatives transactions (other than options)

 

 Class of relevant security

 Product description

e.g. CFD

 Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 Number of reference securities

 Price per unit

 COMMON STOCK

 CFD

 LONG

 33

 28.9300 USD

 COMMON STOCK

 CFD

 LONG

 5

 28.9300 USD

 COMMON STOCK

 CFD

 LONG

 11

 28.9300 USD

 COMMON STOCK

 CFD

 LONG

 18

 28.9300 USD

 COMMON STOCK

 CFD

 LONG

 500

 28.9500 USD

 COMMON STOCK

 CFD

 LONG

 2,000

 28.9525 USD

 COMMON STOCK

 CFD

 LONG

 100

 28.9550 USD

 COMMON STOCK

 CFD

 LONG

 1,500

 28.9700 USD

 COMMON STOCK

 CFD

 LONG

 80

 28.9800 USD

 COMMON STOCK

 CFD

 LONG

 2

 28.9900 USD

 COMMON STOCK

 CFD

 LONG

 773

 28.9935 USD

 COMMON STOCK

 CFD

 LONG

 8,509

 28.9937 USD

 COMMON STOCK

 CFD

 LONG

 1,000

 29.0000 USD

 COMMON STOCK

 CFD

 LONG

 73,000

 29.0106 USD

 COMMON STOCK

 CFD

 LONG

 27,080

 29.0475 USD

 COMMON STOCK

 CFD

 LONG

 4,100

 29.0527 USD

 COMMON STOCK

 CFD

 LONG

 1

 29.0600 USD

 COMMON STOCK

 CFD

 LONG

 4

 29.0600 USD

 COMMON STOCK

 CFD

 LONG

 14,400

 29.2095 USD

 COMMON STOCK

 CFD

 SHORT

 2,100

 28.8800 USD

 COMMON STOCK

 CFD

 SHORT

 2,565

 28.8900 USD

 COMMON STOCK

 CFD

 SHORT

 393

 28.8900 USD

 COMMON STOCK

 CFD

 SHORT

 2

 28.9536 USD

 COMMON STOCK

 CFD

 SHORT

 17

 28.9536 USD

 COMMON STOCK

 CFD

 SHORT

 596

 28.9544 USD

 COMMON STOCK

 CFD

 SHORT

 338

 28.9546 USD

 COMMON STOCK

 CFD

 SHORT

 246

 28.9548 USD

 COMMON STOCK

 CFD

 SHORT

 16,500

 28.9561 USD

 COMMON STOCK

 CFD

 SHORT

 103

 28.9564 USD

 COMMON STOCK

 CFD

 SHORT

 4

 28.9600 USD

 COMMON STOCK

 CFD

 SHORT

 24

 28.9600 USD

 COMMON STOCK

 CFD

 SHORT

 10,300

 28.9733 USD

 COMMON STOCK

 CFD

 SHORT

 12,924

 28.9784 USD

 COMMON STOCK

 CFD

 SHORT

 4,872

 28.9786 USD

 COMMON STOCK

 CFD

 SHORT

 100

 28.9800 USD

 COMMON STOCK

 CFD

 SHORT

 100

 28.9850 USD

 COMMON STOCK

 CFD

 SHORT

 33,708

 28.9888 USD

 COMMON STOCK

 CFD

 SHORT

 100

 28.9900 USD

 COMMON STOCK

 CFD

 SHORT

 3

 29.0000 USD

 COMMON STOCK

 CFD

 SHORT

 3

 29.0000 USD

 COMMON STOCK

 CFD

 SHORT

 29,000

 29.0093 USD

 COMMON STOCK

 CFD

 SHORT

 20,000

 29.0200 USD

 COMMON STOCK

 CFD

 SHORT

 1,788

 29.0437 USD

 COMMON STOCK

 CFD

 SHORT

 162

 29.0438 USD

 COMMON STOCK

 CFD

 SHORT

 4,300

 29.0560 USD

 COMMON STOCK

 CFD

 SHORT

 6,042

 29.0599 USD

 COMMON STOCK

 CFD

 SHORT

 37,700

 29.0720 USD

 COMMON STOCK

 CFD

 SHORT

 10,500

 29.2121 USD

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

 Class of relevant security

 Product description e.g. call option

 Writing, purchasing, selling, varying etc.

 Number of securities to which option relates

 Exercise price per unit

 Type e.g. American, European etc.

 Expiry date

 Option money paid/ received per unit

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 

(ii) Exercising

 

 Class of relevant security

 Product description e.g. call option

 Number of securities

 Exercise price per unit

 N/A

 N/A

 N/A

 N/A

 

(d) Other dealings (including subscribing for new securities)

 

 Class of relevant security

 Nature of dealing e.g. subscription, conversion

 Details

 Price per unit (if applicable)

 N/A

 N/A

 N/A

 N/A

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

Date of disclosure:

08 MAY 2014

Contact name:

Darren Wickert

Telephone number:

+44 (0)20 7425 6578

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERGCGDUUGGBGSI

Related Shares:

AstrazenecaPFZ.L
FTSE 100 Latest
Value8,721.07
Change40.78